Stay updated on Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial

Sign up to get notified when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T20:33:07.000Z thumbnail image
  5. Check
    30 days ago
    No Change Detected
  6. Check
    37 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.
    Difference
    6%
    Check dated 2025-02-10T09:40:50.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T07:23:01.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T22:06:19.000Z thumbnail image
  9. Check
    66 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    1.0%
    Check dated 2025-01-12T17:40:18.000Z thumbnail image
  10. Check
    95 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:33:44.000Z thumbnail image

Stay in the know with updates to Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.